BetterLife Pharma Inc. (BETR.CN)
CAD 0.1
(5.26%)
CAD 0.1
(5.26%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 245.23 Thousand CAD | -79.34% |
| 2022 | 1.18 Million CAD | -14.94% |
| 2021 | 1.39 Million CAD | 179.15% |
| 2020 | 500 Thousand CAD | -89.37% |
| 2019 | 4.7 Million CAD | 34.44% |
| 2018 | 3.49 Million CAD | 1309.23% |
| 2017 | 248.19 Thousand CAD | -31.13% |
| 2016 | 360.38 Thousand CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | -100.0% |
| 2013 | 342.15 Thousand CAD | 55.9% |
| 2012 | 219.47 Thousand CAD | 119.88% |
| 2011 | 99.81 Thousand CAD | 833.02% |
| 2010 | 10.69 Thousand CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.94 Million CAD | 65.33% |
| 2024 Q1 | 1.17 Million CAD | 379.5% |
| 2023 Q4 | 245.23 Thousand CAD | -61.1% |
| 2023 FY | 245.23 Thousand CAD | -79.34% |
| 2023 Q1 | 1.09 Million CAD | -7.86% |
| 2023 Q2 | 1.17 Million CAD | 7.18% |
| 2023 Q3 | 630.39 Thousand CAD | -46.23% |
| 2022 Q2 | 1.62 Million CAD | 13.12% |
| 2022 Q1 | 1.43 Million CAD | 2.98% |
| 2022 Q4 | 1.18 Million CAD | -6.8% |
| 2022 Q3 | 1.27 Million CAD | -21.65% |
| 2022 FY | 1.18 Million CAD | -14.94% |
| 2021 Q2 | 524.83 Thousand CAD | -30.26% |
| 2021 Q3 | 380.16 Thousand CAD | -27.57% |
| 2021 Q4 | 1.39 Million CAD | 267.14% |
| 2021 FY | 1.39 Million CAD | 179.15% |
| 2021 Q1 | 752.54 Thousand CAD | 50.51% |
| 2020 Q2 | 3.28 Million CAD | -0.02% |
| 2020 FY | 500 Thousand CAD | -89.37% |
| 2020 Q4 | 500 Thousand CAD | -87.73% |
| 2020 Q1 | 3.28 Million CAD | -30.22% |
| 2020 Q3 | 4.07 Million CAD | 24.19% |
| 2019 Q2 | 1 Million CAD | -75.2% |
| 2019 FY | 4.7 Million CAD | 34.44% |
| 2019 Q4 | 4.7 Million CAD | 419.07% |
| 2019 Q3 | 905.89 Thousand CAD | -9.64% |
| 2019 Q1 | 4.04 Million CAD | 15.59% |
| 2018 FY | 3.49 Million CAD | 1309.23% |
| 2018 Q4 | 3.49 Million CAD | -2.07% |
| 2018 Q2 | 5.44 Million CAD | 2.56% |
| 2018 Q1 | 5.3 Million CAD | 2038.23% |
| 2018 Q3 | 3.57 Million CAD | -34.38% |
| 2017 Q2 | 491.11 Thousand CAD | -1.66% |
| 2017 FY | 248.19 Thousand CAD | -31.13% |
| 2017 Q4 | 248.19 Thousand CAD | -4.32% |
| 2017 Q3 | 259.4 Thousand CAD | -47.18% |
| 2017 Q1 | 499.4 Thousand CAD | 38.57% |
| 2016 Q3 | 191.29 Thousand CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 FY | 360.38 Thousand CAD | 0.0% |
| 2016 Q4 | 360.38 Thousand CAD | 88.4% |
| 2016 Q1 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2014 FY | - CAD | -100.0% |
| 2014 Q4 | - CAD | -100.0% |
| 2014 Q3 | 392.93 Thousand CAD | 8.01% |
| 2014 Q2 | 363.8 Thousand CAD | 2.38% |
| 2014 Q1 | 355.32 Thousand CAD | 3.85% |
| 2013 Q3 | 242.13 Thousand CAD | 6.81% |
| 2013 Q1 | 221.5 Thousand CAD | 0.92% |
| 2013 Q2 | 226.7 Thousand CAD | 2.35% |
| 2013 FY | 342.15 Thousand CAD | 55.9% |
| 2013 Q4 | 342.15 Thousand CAD | 41.31% |
| 2012 Q2 | 162.35 Thousand CAD | 16.38% |
| 2012 FY | 219.47 Thousand CAD | 119.88% |
| 2012 Q4 | 219.47 Thousand CAD | 631.58% |
| 2012 Q3 | 30 Thousand CAD | -81.52% |
| 2012 Q1 | 139.5 Thousand CAD | 39.76% |
| 2011 Q4 | 99.81 Thousand CAD | 8.96% |
| 2011 Q3 | 91.6 Thousand CAD | -30.67% |
| 2011 Q2 | 132.13 Thousand CAD | -31.49% |
| 2011 Q1 | 192.87 Thousand CAD | 1702.91% |
| 2011 FY | 99.81 Thousand CAD | 833.02% |
| 2010 FY | 10.69 Thousand CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | 10.69 Thousand CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | - CAD | -Infinity% |
| Asep Medical Holdings Inc | 20 Thousand CAD | -1126.17% |
| BioVaxys Technology Corp. | - CAD | -Infinity% |
| ChitogenX Inc. | 3.87 Million CAD | 93.671% |
| Rapid Dose Therapeutics Corp. | 2.45 Million CAD | 90.005% |
| Defence Therapeutics Inc. | 1.74 Million CAD | 85.958% |
| Entheon Biomedical Corp. | - CAD | -Infinity% |
| Gemina Laboratories Ltd. | 285.32 Thousand CAD | 14.051% |
| Glow Lifetech Corp. | 116.18 Thousand CAD | -111.074% |
| Lexston Life Sciences Corp. | - CAD | -Infinity% |
| Pharmala Biotech Holdings Inc. | 253.53 Thousand CAD | 3.275% |
| Doseology Sciences Inc. | - CAD | -Infinity% |
| MYND Life Sciences Inc. | 3 Million CAD | 91.826% |
| Nova Mentis Life Science Corp. | - CAD | -Infinity% |
| PharmaTher Holdings Ltd. | - CAD | -Infinity% |
| PreveCeutical Medical Inc. | 3.83 Million CAD | 93.604% |
| Telescope Innovations Corp. | - CAD | -Infinity% |